×

Kraig Biocraft Laboratories Named Finalist for Two ITMA Future Materials Awards 2014 Categories

LANSING, Mich., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, announced today that the Company was named finalist in two categories for Internationale Textilmaschinen Ausstellung's ("ITMA") Future Materials Awards 2014.

"I would like to thank ITMA, the world's largest international textile machinery exhibition, for recognizing our technology and efforts, and congratulate the other finalists for making the shortlist. I believe that the recognition in the 'Most innovative small company' and 'Best innovation, Agrotextiles' categories is a testament to our team, our technology and our shareholders," said Kraig CEO and founder, Kim K. Thompson.

Further ITMA Future Materials Awards 2014 information can be viewed at the following link: www.futurematerialsawards.com

Finalists can be viewed at the following link: www.futurematerialsawards.com/finalists.html

Further ITMA information can be viewed at the following link: www.cematex.com/whatisitma.cfm

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc